Literature DB >> 7527068

Chamber for testing metered-dose propellant-driven aerosols of immunologically relevant proteins.

A R Brown1, J A Pickrell.   

Abstract

A small aerosol chamber was developed for testing and delivery of aerosols of immunologically important proteins to the respiratory tracts of rodents. The chamber was designed to accommodate the small aerosol volumes produced by metered-dose propellant-driven aerosol canisters. Metered bursts of protein aerosols released into the chamber could be sampled for their particle sizes or used to expose the noses of up to six mice to the aerosols. The chamber consisted of a polyethylene tank with two removable plexiglass end plates. One end plate accommodated the propellant-driven, metered-dose, aerosol vial. The other end of the tank was fitted with a plate accepting aerosol sampling devices or a plate containing mouse restrainers. Uniform concentrations of aerosolized proteins were obtained at different positions in the chamber when sampled for particles of respirable size. Respirable-sized protein particles produced by propellant-driven aerosols ranged from 5 to 50% of total aerosolized protein. Propellant-driven aerosols of proteins released in the chamber produced aerosol particles equivalent to 15-26 micrograms of total protein exposure to the respiratory tract of each mouse. The chamber permitted aerosol releases without risk of operator exposure. This aerosol chamber will permit the testing of protein aerosols for their immunologic consequences to the respiratory tract. Potential proteins for testing in this device include immunizing vaccine antigens, immunomodulating cytokine proteins, and passive antibody aerosol therapies against respiratory infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527068     DOI: 10.1016/0022-1759(94)90314-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

1.  Tetrafluoroethane (HFC 134A) propellant-driven aerosols of proteins.

Authors:  A R Brown; D W George
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.